Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds
A Clinical Evaluation of the Current™ Radio Frequency (RF) Implantable Cardioverter Defibrillator (ICD) Models 2215/1215 and Promote™ RF Cardiac Resynchronization Therapy Defibrillator (CRT-D) Model 3215 Pulse Generators
Sponsor: Abbott Medical Devices
A NA clinical study on Heart Failure and Ventricular Arrythmias, this trial is completed. The trial is conducted by Abbott Medical Devices and has accumulated 8 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
-
Feb 2019 — Mar 2019 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jun 2018 — Feb 2019 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Aug 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott Medical Devices
For direct contact, visit the study record on ClinicalTrials.gov .